Edit |   |
---|---|
Product Name | Carfilzomib |
Description | Carfilzomib is a small molecule which can act as a Proteasome inhibitor. It is provided as a powder. This product acts on the following target types: Proteasome. This product acts on the following biochemical pathways: Degradation, Cell cycle, Apoptosis inducer, Cytotoxicity. This product may be of interest in the following research areas and diseases: Ubiquitin/Proteasome, Cell death, Cancer. This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, probably through blocking the main protease, Mpro (3CLpro, Nsp5). Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 719.93 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Carfilzomib, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]- L-Phenylalaninamide, PR-171, 868540-17-4 |
Gene, Accession, CAS # | CAS: 868540-17-4 |
Catalog # | abx076715 |
Price | please inquire |
Order / More Info | Carfilzomib from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950